Boric Acid Suppositories for Vaginal Yeast Infections
Boric acid suppositories are primarily recommended as a second-line treatment for non-albicans Candida infections, particularly C. glabrata, that are unresponsive to standard azole therapies. 1
Primary Role in Treatment
Boric acid serves a specific niche in the management of vaginal yeast infections:
First-line treatments for uncomplicated vulvovaginal candidiasis remain:
Boric acid's specific indications:
Dosing and Administration
When boric acid is indicated, the recommended regimen is:
- 600 mg intravaginal boric acid in a gelatin capsule
- Applied daily for 14 days 1, 2
- FDA-recognized use: "treats vaginal yeast infections" and "relieves itching and discomfort due to vaginal yeast infection" 4
Efficacy
Boric acid has demonstrated effectiveness in specific scenarios:
- Mycologic cure rates range from 40% to 100% 3
- Particularly effective against non-albicans Candida species and azole-resistant strains 3, 5
- Acts through multiple mechanisms:
- Inhibition of oxidative metabolism in yeast cells
- Interference with biofilm development
- Inhibition of hyphal transformation 5
Safety Considerations
Common side effects:
- Vaginal burning sensation (occurs in <10% of cases)
- Watery discharge during treatment
- Vaginal erythema 3
Pregnancy considerations:
Important precaution: Boric acid is for vaginal use only and should never be taken orally as it can be toxic if ingested 3
Alternative Options for Non-albicans Infections
When boric acid is not suitable, other options for C. glabrata infections include:
- Nystatin intravaginal suppositories (100,000 units daily for 14 days) 1, 2
- Topical 17% flucytosine cream alone or combined with 3% amphotericin B cream daily for 14 days 1
Management Algorithm
For initial uncomplicated yeast infection:
- Use standard azole therapy (oral fluconazole or topical antifungals)
If symptoms persist or recur:
- Obtain culture to identify Candida species
If C. glabrata or non-albicans species identified:
- Initiate boric acid 600 mg intravaginally daily for 14 days
If boric acid fails or is contraindicated:
- Consider nystatin suppositories or flucytosine cream
For recurrent infections:
Clinical Pearls
- Boric acid is not FDA-approved as a drug but is widely used clinically and recommended in treatment guidelines 6
- Boric acid appears to be fungistatic at lower concentrations and fungicidal at higher concentrations 5
- Its mechanism differs from azoles, making it effective against resistant strains 5
- While some complementary medicine reviews support boric acid use for resistant infections, they note the overall poor quality of available evidence 7